New Launches Support Tandem Diabetes Stock Despite Macro Concerns [Yahoo! Finance]
Tandem Diabetes Care, Inc. (TNDM)
Last tandem diabetes care, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.tandemdiabetes.com
Company Research
Source: Yahoo! Finance
Tandem Diabetes is driving transformative innovation to help reduce the burden and create new possibilities for people living with diabetes. During the second quarter, its flagship t:slim X2 insulin pump software became compatible with Dexcom G7. It was already compatible with Dexcom G6 Continuous Glucose Monitoring (CGM) systems. Following this development, t:slim X2 was approved for sale by Canada Health. In 2023, it was launched in the United States. t:slim X2 became the first automated insulin delivery (AID) system to integrate with Abbott's new FreeStyle Libre 2 Plus sensor in 2023. The breakthrough development has enabled t:slim X2 users in the United States to benefit from a hybrid closed-loop system that helps predict and prevent high and low blood sugar levels. Within the digital health platforms segment, the company began the launch of Tandem Source outside the United States. The latest addition to the pump platform portfolio, Tandem Mobi, is leading the way in creating
Show less
Read more
Impact Snapshot
Event Time:
TNDM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TNDM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TNDM alerts
High impacting Tandem Diabetes Care, Inc. news events
Weekly update
A roundup of the hottest topics
TNDM
News
- Tandem Diabetes Care, Inc. (NASDAQ: TNDM) had its "equal weight" rating re-affirmed by analysts at Morgan Stanley. They now have a $45.00 price target on the stock.MarketBeat
- Tandem secures approval for t:slim X2 insulin pump to use with Lyumjev [Yahoo! Finance]Yahoo! Finance
- Why Tandem Diabetes Care Stock Thrashed the Market Today [Yahoo! Finance]Yahoo! Finance
- Tandem t:slim X2 Insulin Pump Now Compatible with Lyumjev Ultra-rapid Acting Insulin in European UnionBusiness Wire
- Reasons to Hold Tandem Diabetes Stock in Your Portfolio Now [Yahoo! Finance]Yahoo! Finance
TNDM
Earnings
- 8/1/24 - Beat
TNDM
Sec Filings
- 9/18/24 - Form 4
- 9/9/24 - Form SC
- 8/19/24 - Form 4
- TNDM's page on the SEC website